A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium

2013 ◽  
Vol 60 (11) ◽  
pp. 1868-1874 ◽  
Author(s):  
Alexandra P. Zorzi ◽  
Mark Bernstein ◽  
Yvan Samson ◽  
Donna A. Wall ◽  
Sunil Desai ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document